Antiviral remdesivir, now in clinical trials here, could be the best hope to combat COVID-19. But statements by President Trump have put the spotlight on antimalarial drugs of unproven effectiveness against the coronavirus.
Health & Science
Using AI to help heart surgeons
|
RIT associate professor Linwei Wang leads a team of researchers and clinicians working to improve care for arrhythmia and other cardiac diseases.
Health & Science
Mounting evidence against flavored e-cigarettes
|
A new study by four local researchers identifies risks associated with long-term use of flavored vaping pods.
Health & Science
UR research center launches with federal grant
|
The Roybal Center for Social Ties & Aging Research is funded by $3.6 million from the National Institutes of Health.
GUEST OPINION
Managing pain with fewer or no opioids
|
Modern pain management techniques reduce the need for opioid prescriptions.
Health & Science
A brain science breakthrough at UR
|
Researchers at the Del Monte Institute for Neuroscience believe they have identified why brain-cancer patients who have cranial radiotherapy experience cognitive impairment.
Health & Science
URMC participates in cancer-care research
|
A relatively high rate of admissions after cancer patient ED visits suggests a need for better coordination among oncologists and other care providers.
Health & Science
Hot on the trail of a scourge
|
URMC research scientist Irfan Rahman is relentlessly pursuing clues that might help explain the growing number of vaping-related lung injuries and determine the long-term effects of inhaling vaporized oil.
Health & Science
New insight on suicide prevention
|
Research by a UR professor and others shows the importance of strong social networks among high school students.
Health & Science
A market that’s virtually unlimited
|
Use of virtual reality and augmented reality in health care is limited today. Local researchers say that could change in a big way.
Health & Science
UR lands more than $40 million in research funding
|
A team working on infections and overactive immune responses and another at the Wilmot Cancer Institute received the grants.